Napsin A antibody [N1C2]

Eine Lieferung in diese Region ist nicht möglich.

SKU:: GTX109006
Zusätzliche Namen:: napsin A aspartic peptidase , KAP , Kdap , NAP1 , NAPA , SNAPA
Anwendung:: WB
Konzentration:: 0.57 mg/ml
Physischer Zustand:: Liquid
Spezies-Reaktivität:: Human
Aufreinigung:: Affinity Purified
Lagerbedingungen:: -20[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., 2-8[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., -20[o]C/-70[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted.
Hersteller:: Genetex
Host:: Rabbit
Reaktivitäten:: Human
Buffer:: 0.1M Tris, 0.1M Glycine, 10% Glycerol, 0.01% Thimerosal.
Immunogen:: Recombinant protein encompassing a sequence within the center region of human Napsin A. The exact sequence is proprietary.
Klon:: N1C2
Uniprot:: O96009
Synonyme:: asp 4;ASP4;aspartyl protease 4;KAP;Kdap;kidney-derived aspartic protease-like protein;NAP1;NAPA;napsin-1;napsin-A;pronapsin A;SNAPA;TA01/TA02
Weitere Details:: The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus. [provided by RefSeq]